The Tuberculosis Treatment Pipeline: A Breakthrough Year for the Treatment of XDR-TB
July 2017 By Marcus Low Editor's note: This version has been modified from the original print version on August 7, 2017 to reflect recent updates and clarify the status of access to delamanid. INTRODUCTION Arguably, the most critical questions in…
The Tuberculosis Diagnostics and Treatment Pipeline for Children
July 2017 By Lindsay McKenna INTRODUCTION An unacceptable disparity exists between the estimated burden of tuberculosis (TB) in children and the number actually diagnosed and put on TB treatment each year. In 2015, just 384,300 of an estimated one million…
The TB Prevention Pipeline
July 2017 By Mike Frick INTRODUCTION One of the tuberculosis (TB) field’s most often voiced truisms has been that one-third of humanity is infected with Mycobacterium tuberculosis (MTB), the causative agent of TB disease. This estimate is invoked so frequently…
The Tuberculosis Diagnostics Pipeline
July 2017 By Erica Lessem INTRODUCTION Diagnosing tuberculosis (TB) is the first step to being able to treat it and prevent transmission. New guidelines from the World Health Organization (WHO) note that diagnosis should be “available free of charge to…
Engaging Your Policy Makers Ahead of the TB Ministerial Conference
Original air date: June 6, 2017 - In November, Ministers of Health and Finance from 56 of the most high burden TB countries will gather in Moscow for the first ever Ministerial Conference on TB. This webinar provided participants with specific skills…
TAG Earns Coveted 4-Star Rating from Charity Navigator
Advocating for TB Research Funding for BRICS and Beyond
Original air date - MAY 30, 2017 Inadequate funding for research has contributed to programs' inability to adequately address tuberculosis (TB), the leading infectious killer in the world. The first-ever Ministerial Conference on ending TB will be held in Moscow…